Late-Breaking Abstracts

2020 Late-Breaking Abstract Submission is now open

 

The deadline to submit a Late-Breaking Abstract has been extended to June 15, 2020.

 

Submit Late-Breaking Abstract

Open AllClose All
  MDS Late-Breaking Abstract Criteria

Late-Breaking Abstracts will be considered for the MDS Virtual Congress 2020 if they fulfill the following criteria:

  1. The topic must be of critical importance to the clinical/scientific community and/or the public.
  2. The abstract must be report data that became available for public dissemination only after the deadline of the regular abstract submission (March 1, 2020), and has not been previously published or presented.
  3. The study and results reported should be novel (not simply an extension of previously published work) or be definitive of confirming or refuting other critically important work.
  4. The following categories are typically suited to the main poster sessions and will not be considered for Late-Breaking Abstracts: case reports, qualitative surveys, reviews of existing treatments, practice reviews, rating scale validation, small confirmatory studies, small scale epidemiology studies, research proposals.
  5. The Late-Breaking Abstract program is not designed to favor investigators who inadvertently missed the deadline for regular abstract submission.

The following types of studies are NOT appropriate for the Late-Breaking Abstract program and will not be considered for acceptance: 

  • case reports or small series of cases
  • replication studies
  • descriptions of study designs or plans with no presentation of data
  • extensions of previously reported studies
  • qualitative surveys
  • reviews of existing treatments
  • practice reviews
  • rating scale validation
  • research proposals

The Late-Breaking Abstract submission process is not intended for regular abstract submissions that inadvertently missed the 2020 deadline, and does not accept encore submissions.

 

  Abstract Submission Guidelines

Text limit of 2,500 characters (including spaces). The size limit includes characters and spaces in the Abstract Title and Abstract Body. Please note that spaces are included in the overall character count. The size limit does not include author information.

Abstracts should be arranged as follows:

  • Objective
  • Background
  • Methods
  • Results
  • Conclusions

Do not include any identifying information directly on the abstract.

Only non-proprietary (generic) drug names should be used and should be written without capitals.

Do not include branded product names in the abstract. If the abstract is found to contain marketing, rather than scientific content, the abstract will be rejected.

A special or unusual abbreviation should be placed in parentheses after the first appearance of the full word for which it stands.

Please note there is a separate upload field for tables and graphs. To include tables or figures, enter the appropriate ID tag within the abstract body where the tables and/or figures should appear. Tags must be entered as shown - [table1] for your first table; [table2] for your second table; [figure1] for your first figure; [figure2] for your second figure.

To list references, enter the appropriate ID tag. [1] for your first reference, [2] for your second reference, [3] for your third reference, etc.

  Submission and Eligibility

Late-Breaking Abstract submissions must be received by June 15, 2020, 11:59PM CDT.

The sole means of submission is via the Internet. Please do not e-mail, fax, or mail submissions.

Late-Breaking Abstracts must be submitted and presented in English.

MDS members and non-members are eligible to submit Late-Breaking Abstracts.

There is no fee for submitting an MDS abstract.

MDS does not offer CME credit for poster viewing or submitted abstracts.

MDS International Congress faculty are not required to submit an abstract.

  Previously Published Abstracts and Plagiarism

Late-Breaking Abstract submissions must report data that became available for public dissemination only after the deadline of the regular abstract submission (March 1, 2020), and may not have been previously published or presented.

If you are planning to present or publish your work elsewhere prior to the MDS Virtual Congress 2020, please do not submit the work as a Late-Breaking Abstract.

All submitted abstracts will be run through an online plagiarism detection software. Should plagiarism be detected, the abstract will be rejected.

All abstracts presented at a previous MDS International Congress have been published by MDS.

  Review

The Chairs of the MDS Congress Scientific Program Committee (CSPC) will review all Late-breaking abstract submissions in June of 2020. The CSPC Chairs shall be directed to reject abstracts for the following reasons:

  • Does not meet the full criteria of an MDS Late-Breaking Abstract (please see MDS Late-Breaking Abstract Criteria)
  • Plagiarism detected
  • Marketing detected
  • Subject not related to the field of Movement Disorders

All submitted abstracts will be run through an online plagiarism detection software. Should plagiarism be detected, the abstract will be rejected.

  Notification and Correspondence

All notifications regarding a submitted abstract will be sent only to the person identified in the “contact information” section of the submission form. It is expected that the contact person will circulate updates regarding the abstract as needed.

All successfully submitted abstracts will receive a confirmation e-mail to the designated contact person. If the confirmation e-mail has not been received within 24-hours of submitting the abstract, please contact the MDS at congress@movementdisorders.org to verify the status of the submission.

Abstract acceptance notifications will be sent to the designated contact person via e-mail in July 2020.

All confirmed abstract submissions will be reviewed for acceptance by MDS.

Please ensure that congress@movementdisorders.org is designated as a “safe senders” to ensure timely correspondence regarding the abstract submission.

Please check your spam and junk e-mail folders before contacting MDS regarding the status of your abstract. Abstract notices will come from congress@movementdisorders.org.

  Withdrawing a Submitted Abstract

June 15 – July 30, 2020

Requests to withdraw a submitted abstract must be received in writing by July 30, 2020, to congress@movementdisorders.org. There is no penalty to withdraw your abstract.

July 30, 2020 – Onward
After July 30, 2020, your abstract cannot be withdrawn and will remain a part of the 2020 MDS published abstracts. All submitted abstracts become the property of MDS.

  Publication of Accepted Abstracts

All accepted Late-Breaking Abstracts will be published on the 2020 International Congress website as a downloadable PDF. Citation information will be available on the publication website September 13, 2020.

  Abstract Presentation

All accepted abstracts will be offered the opportunity to submit a PDF of their poster for presentation as an e-poster in the MDS Virtual Congress 2020 poster catalog. Details will be provided in accepted abstract notification letters. Please watch for further information and announcements via email and social media in the coming months.

If you prefer not to publish your abstract or case study without the opportunity to present your work in person, please withdraw your submission by JULY 1, 2020 by visiting https://catalyst.omnipress.com. There is no penalty or consequence to withdraw your work, and you are welcome to resubmit a withdrawn submission for a future MDS International Congress.



2019 Nice International Congress Late-Breaking Abstract Publication

2019 International Congress Late-Breaking Abstracts (PDF)

To cite an MDS published Late-Breaking Abstract, follow this example:

[Author’s Last Name], [Author’s First and Middle Initials]. (2019). International Congress of Parkinson’s Disease and Movement Disorders. Late-Breaking Abstracts, [Abstract Title], [pages].

Retrieved from www.mdscongress.org/Congress/Program--Abstracts.htm.



Late-Breaking Abstract Publications Archive

To view the archive of International Congress Late-Breaking Abstracts, visit the MDS Past / Future Congresses webpage.

To cite an MDS published Late-Breaking Abstract, follow this example:

[Author’s Last Name], [Author’s First and Middle Initials]. (year). International Congress of Parkinson’s Disease and Movement Disorders. Late-Breaking Abstracts, [Abstract Title], [pages].
Retrieved from https://www.mdscongress.org/Congress/Program--Abstracts/View-Past--Future-Congresses.htm.


For More Information

International Secretariat
555 East Wells Street, Suite 1100
Milwaukee, WI 53202 USA
Phone: +1 (414) 276-2145
Fax: +1 (414) 276-3349
E-mail: congress@movementdisorders.org

Add Name to International Congress Mailing List

Top

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice